Announcement on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd., the listing and circulation of restricted shares
Innocare Pharmaceutical Co., Ltd.'s Announcement on Changes in Shareholders' Equity of More Than 5%
Innocare Pharmaceuticals Limited Summary of Changes in Equity Report
Innocare Pharmaceutical Co., Ltd. announcement of the first attribution period and stock listing of the 2023 Star Market Restricted Stock Incentive Plan.
InnoCare Pharma: According to the stock-based incentive plan in 2023, restricted share units were granted.
Legal Opinion of Fangda Law Firm, Shanghai regarding the Achievements of the First Vesting Period and Cancellation of Some Restricted Stocks in the 2023 Star Restricted Stock Incentive Plan of Innocare Pharmaceutical Co., Ltd.
Innocare Pharmaceutical Co., Ltd.'s announcement on the first attribution period of the 2023 STAR market restricted stock incentive plan partially meeting the attribution conditions.
InnoCare Pharma: VOLUNTARY ANNOUNCEMENT The CEO and Executive Director increased their shareholding in the Company
Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on granting reserved restricted shares to incentive recipients
Legal Opinion of Shanghai Fangda Law Firm on matters relating to the reservation grant of InnoCare Pharma Limited (InnoCare Pharma Limited)'s 2023 Science and Technology Innovation Board Restricted Stock Incentive Plan
Nuochengjianhua Pharmaceutical Co., Ltd. 2023 Science and Technology Innovation Board Restricted Stock Incentive Plan Reservation Grant Date Incentive List (as of the reservation grant date)
Hong Kong Stock Announcement: Grant of Restricted Share Units under the 2023 Equity Incentive Plan
Hong Kong Stock Notice: Grant of Restricted Share Units under the 2023 Equity Incentive Scheme
Nuocheng Jianhua Pharmaceutical Co., Ltd.\'s initial public offering strategic placement of restricted shares listing and circulation announcement
Hong Kong Stock Notice: Voluntary Announcement of On-Market Share Repurchase
Hong Kong Stock Announcement: Suspension of share transfer registration procedures
Self-inspection report of Nuocheng Jianhua Pharmaceutical Co., Ltd. on the 2023 Science and Technology Innovation Board Restricted Stock Incentive Plan insider information on how insiders traded the company\'s shares
Announcement of Nuocheng Jianhua Pharmaceutical Co., Ltd. on awarding restricted shares for the first time to incentive targets
Legal opinion of Shanghai Fangda Law Firm on matters relating to the first award of the 2023 Science and Technology Innovation Board restricted stock incentive plan by InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuocheng Jianhua Pharmaceutical Co., Ltd. 2023 Science and Technology Innovation Board Restricted Stock Incentive Plan First Grant Date List (as of the first grant date)
No Data
No Data